CORMORANT ASSET MANAGEMENT, LP purchased 3.2% of their position (2.15M shares) of AMBRX BIOPHARMA CAYMAN, INC. on the open market
Open‑market purchase worth $19.63M — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 9/19/2023ACC: 0000929638-23-002564
10% Owner
Since Mar 2023
+2.15M
Net shares
Net buyer
$19.63M
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
2.15M acquired
Non-Derivative Transactions2
Ordinary Shares
Indirect
Shares
+1.40M
Price / share
$9.05
Trade value
$12.68M
% of position
2.1%
9/15/2023
67.31M→68.71M
Ordinary Shares
Indirect
Shares
+751.23K
Price / share
$9.24
Trade value
$6.94M
% of position
1.1%
9/18/2023
68.71M→69.47M
Total
Net shares
+2.15M
Net value
$19.63M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Indirect | 9/15/2023 | P · Purchase | +1.40M | $9.05 | $12.68M | 2.1% | 67.31M | 68.71M |
| Ordinary Shares Indirect | 9/18/2023 | P · Purchase | +751.23K | $9.24 | $6.94M | 1.1% | 68.71M | 69.47M |
| Total | +2.15M | $19.63M | ||||||
Derivative Transactions0
No derivative transactions reported